{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:21:44Z","timestamp":1790313704476,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s15010-023-01984-2","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T03:02:37Z","timestamp":1674615757000},"page":"1319-1327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Impact of severe lymphopenia on the early prediction of clinical outcome in hospitalized patients with pneumococcal community-acquired pneumonia"],"prefix":"10.1007","volume":"51","author":[{"given":"Luis A.","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyre","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"Urrutia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane","family":"Uranga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"Artaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhoa","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro P.","family":"Espa\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Zalacain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"1984_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/thx.2009.129502","volume":"67","author":"T Welte","year":"2012","unstructured":"Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67:71\u20139.","journal-title":"Thorax"},{"key":"1984_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/MCC.0000000000000340","volume":"22","author":"C Feldman","year":"2016","unstructured":"Feldman C, Anderson R. Community-acquired pneumonia. Still a major burden of disease. Curr Opin Crit Care. 2016;22:477\u201384.","journal-title":"Curr Opin Crit Care"},{"key":"1984_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204\u201322.","journal-title":"Lancet"},{"key":"1984_CR4","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/thx.2008.109785","volume":"64","author":"S Ewig","year":"2009","unstructured":"Ewig S, Birkner N, Strauss R, et al. New perspectives on community-acquired pneumonia in 388.406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax. 2009;64:1062\u20139.","journal-title":"Thorax"},{"key":"1984_CR5","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1183\/09031936.00154209","volume":"36","author":"J Phua","year":"2010","unstructured":"Phua J, Ngerng WJ, Lim TK. The impact of a delay in intensive care unit admission for community-acquired pneumonia. Eur Respir J. 2010;36:826\u201333.","journal-title":"Eur Respir J"},{"key":"1984_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ebiom.2017.09.023","volume":"24","author":"JF Bermejo-Martin","year":"2017","unstructured":"Bermejo-Martin JF, Cilloniz C, Mendez R, for the NEUMONAC group, et al. Lymphopenic community-acquired pneumonia (L-CAP), an immunological phenotype associated with higher risk of mortality. EBioMedicine. 2017;24:231\u20136.","journal-title":"EBioMedicine"},{"key":"1984_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab169","author":"C Cilloniz","year":"2021","unstructured":"Cilloniz C, Peroni HJ, Gabarrus A, et al. Lymphopenia is associated with poor outcomes of patients with community-acquired pneumonia and sepsis. OFID. 2021. https:\/\/doi.org\/10.1093\/ofid\/ofab169.","journal-title":"OFID"},{"key":"1984_CR8","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/jcm8060843","volume":"8","author":"C Ceccato","year":"2019","unstructured":"Ceccato C, Panagiotarakou M, Ranzani OT, et al. Lymphocytopenia as a predictor of mortality in patients with ICU-acquired Pneumonia. J Clin Med. 2019;8:848.","journal-title":"J Clin Med"},{"key":"1984_CR9","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/jcm8050754","volume":"8","author":"E G\u00fcell","year":"2019","unstructured":"G\u00fcell E, Martin-Fernandez M, de la Torre MC, et al. Impact of lymphocyte and neutrophil counts on mortality risk in severe community-acquired pneumonia with or without septic shock. J Clin Med. 2019;8:754.","journal-title":"J Clin Med"},{"key":"1984_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/thx.2010.143982","volume":"66","author":"C Cilloniz","year":"2011","unstructured":"Cilloniz C, Ewig S, Polverino E, et al. Microbial etiology of community-acquired pneumonia and its relation to severity. Thorax. 2011;66:340\u20136.","journal-title":"Thorax"},{"key":"1984_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1055\/s-0036-1592074","volume":"37","author":"C Feldman","year":"2016","unstructured":"Feldman C, Anderson R. The role of streptococcus pneumonia in community-acquired pneumonia. Semin Respir Crit Care Med. 2016;37:806\u201318.","journal-title":"Semin Respir Crit Care Med"},{"key":"1984_CR12","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1513\/AnnalsATS.201505-304OC","volume":"12","author":"L Molinos","year":"2015","unstructured":"Molinos L, Zalacain R, Menendez R, et al. Sensitivity, specificity and positivity predictors of the pneumococcal urinary antigen test in community-acquired pneumonia. Ann Am Thorac Soc. 2015;12:1482\u20139.","journal-title":"Ann Am Thorac Soc"},{"key":"1984_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1378\/chest.119.1.243","volume":"119","author":"J Dominguez","year":"2001","unstructured":"Dominguez J, Gali N, Blanco S, et al. Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest. 2001;119:243\u20139.","journal-title":"Chest"},{"key":"1984_CR14","unstructured":"U.S. National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. [(accessed on 1 April 2022)]; 2017\u00a0Available online:\u00a0https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf."},{"key":"1984_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJM199701233360402","volume":"336","author":"MJ Fine","year":"1997","unstructured":"Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243\u201350.","journal-title":"N Engl J Med"},{"key":"1984_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.arbres.2010.06.014","volume":"46","author":"R Men\u00e9ndez","year":"2010","unstructured":"Men\u00e9ndez R, Torres A, Aspa J, et al. Community-acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR). Arch Bronconeumol. 2010;46:543\u201358.","journal-title":"Arch Bronconeumol"},{"key":"1984_CR17","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/cid\/ciy723","volume":"68","author":"MF Di Pasquale","year":"2019","unstructured":"Di Pasquale MF, Sotgiu G, Gramegna A, et al. Prevalence and etiology of community-acquired pneumonia in immunocompromised patients. Clin Infect Dis. 2019;68:1482\u201393.","journal-title":"Clin Infect Dis"},{"key":"1984_CR18","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink M, Marshall JC, et al. 2001 SCCM\/ESICM\/ATS\/SIS international sepsis definitions conference. Crit Care Med. 2003;31:1250\u20136.","journal-title":"Crit Care Med"},{"key":"1984_CR19","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/thx.2003.017756","volume":"59","author":"R Men\u00e9ndez","year":"2004","unstructured":"Men\u00e9ndez R, Torres A, Zalacain R, et al. Risk factors to treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004;59:960\u20135.","journal-title":"Thorax"},{"key":"1984_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200504","volume":"13","author":"C Cilloniz","year":"2018","unstructured":"Cilloniz C, Liapikou A, Martin-Loeches I, et al. Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia. PLoS ONE. 2018;13: e0200504.","journal-title":"PLoS ONE"},{"key":"1984_CR21","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","volume":"81","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Peng F, Xu B, Zhao J, et al. Risk factors of critical and mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81:e16-25.","journal-title":"J Infect"},{"key":"1984_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijid.2021.11.023","volume":"115","author":"L Serrano Fern\u00e1ndez","year":"2022","unstructured":"Serrano Fern\u00e1ndez L, Ruiz Iturriaga LA, Espa\u00f1a Yandiola PP, et al. Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities. Int J Infect Dis. 2022;115:39\u201347.","journal-title":"Int J Infect Dis"},{"key":"1984_CR23","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/cid\/ciy829","volume":"68","author":"DR Murdoch","year":"2019","unstructured":"Murdoch DR. Indications for microbiological testing in pneumonia: Which patients should be tested? Clin Infect Disease. 2019;68:2034\u20135.","journal-title":"Clin Infect Disease"},{"key":"1984_CR24","first-page":"iii1","volume":"69","author":"WS Lim","year":"2009","unstructured":"Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community-acquired pneumonia in adults: update 2009. Thorax. 2009;69:iii1\u201355.","journal-title":"Thorax"},{"key":"1984_CR25","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s11739-016-1445-3","volume":"11","author":"E Constantini","year":"2016","unstructured":"Constantini E, Allara E, Patrucco F, et al. Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality. Intern Emerg Med. 2016;11:929\u201340.","journal-title":"Intern Emerg Med"},{"key":"1984_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jinf.2019.04.006","volume":"78","author":"R M\u00e9ndez","year":"2019","unstructured":"M\u00e9ndez R, Men\u00e9ndez R, Amara-Elori I, et al. Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality. J Infect. 2019;78:423\u201331.","journal-title":"J Infect"},{"key":"1984_CR27","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1183\/09031936.00074410","volume":"37","author":"H Enderman","year":"2011","unstructured":"Enderman H, Meijivis SCA, Rijkers GT, et al. Systemic cytokine response in patients with community-acquired pneumonia. Eur Resp J. 2011;37:1431\u20138.","journal-title":"Eur Resp J"},{"key":"1984_CR28","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3390\/jcm8091461","volume":"8","author":"A Torres","year":"2019","unstructured":"Torres A, Ceccato A, Ferrer M, et al. Effect of corticosteroids on C-reactive protein in patients with severe community acquired pneumonia and high inflammatory response: the effect of lymphopenia. J Clin Med. 2019;8:1461.","journal-title":"J Clin Med"},{"key":"1984_CR29","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1183\/09031936.00128107","volume":"32","author":"C Garcia-Vidal","year":"2008","unstructured":"Garcia-Vidal C, Fernanadez-Sab\u00e9 N, Carratal\u00e1 J, et al. Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J. 2008;32:733\u20139.","journal-title":"Eur Respir J"},{"key":"1984_CR30","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1046\/j.1469-0691.2003.00679.x","volume":"9","author":"D Genn\u00e8","year":"2003","unstructured":"Genn\u00e8 D, Kaiser L, Kinge TN, et al. Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials. Clin Microbiol Infect. 2003;9:949\u201354.","journal-title":"Clin Microbiol Infect"},{"key":"1984_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1164\/ajrccm.162.1.9907023","volume":"162","author":"F Arancibia","year":"2000","unstructured":"Arancibia F, Ewig S, Martinez JA. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Crit Care Med. 2000;162:154\u201360.","journal-title":"Am J Crit Care Med"},{"key":"1984_CR32","doi-asserted-by":"publisher","first-page":"e00787","DOI":"10.1128\/JCM.00787-17","volume":"56","author":"H Shoji","year":"2018","unstructured":"Shoji H, Domenech A, Simonetti AF, et al. The Alere BinaxNow pneumococcal urinary antigen test: diagnostic sensitivity for adult pneumococcal pneumonia and relationship to specific serotypes. J Clin Microbiol. 2018;56:e00787-e817.","journal-title":"J Clin Microbiol"},{"key":"1984_CR33","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.vaccine.2019.11.026","volume":"38","author":"C Forstner","year":"2020","unstructured":"Forstner C, Kolditz M, Kessemeier M, et al. Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia. Vaccine. 2020;38:1129\u201336.","journal-title":"Vaccine"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-023-01984-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-023-01984-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-023-01984-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:02:59Z","timestamp":1744210979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-023-01984-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1984"],"URL":"https:\/\/doi.org\/10.1007\/s15010-023-01984-2","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"16 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflict of interest related to this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Drug Research Ethics Committee of the Basque Country (Comit\u00e9 de Etica de Investigaci\u00f3n con Medicamentos de Euskadi, approval reference number: EPA2019043).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}